Koate-DVI is approved by the Food and Drug Administration (FDA) to control and prevent bleeding in adults with hemophilia A. Koate-DVI can also be used for perioperative (before, during, and after surgery) care. The technical name of Koate-DVI is Antihemophilic factor (human).
Koate-DVI is a clotting factor. Clotting factors work by supplying proteins missing in people with hemophilia.
How do I take it?
Prescribing information states that Koate-DVI is given as an intravenous injection.
Koate-DVI comes as a powder that must be reconstituted before injection.
The FDA-approved label for Koate-DVI lists common side effects including blurred vision, tingling sensation, headache, abdominal pain, jitters, and nausea.
Rare but serious side effects listed for Koate-DVI include the transmission of infections.